{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:52:41Z","timestamp":1792011161428,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":279,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012434","name":"Middle-aged and Young Teachers' Basic Ability Promotion Project of Guangxi","doi-asserted-by":"publisher","award":["2025KY0549"],"award-info":[{"award-number":["2025KY0549"]}],"id":[{"id":"10.13039\/501100012434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009329","name":"Guangxi Science and Technology Plan Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160550"],"award-info":[{"award-number":["82160550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101476","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:47:27Z","timestamp":1791917247000},"page":"101476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CAD potentially mediates 5\u2011fluorouracil resistance in gastric cancer cells via modulation of uridine monophosphate synthetase expression"],"prefix":"10.1016","volume":"49","author":[{"given":"Yixin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5376-822X","authenticated-orcid":false,"given":"Yaowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2026.101476_bib0001","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1574892816666210929165729","article-title":"Current advances and outlook in gastric cancer chemoresistance: a review","volume":"17","author":"Zhang","year":"2022","journal-title":"Recent. Pat. AntiCancer Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101476_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103841","article-title":"Characteristics of gastric cancer around the world","volume":"181","author":"L\u00f3pez","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ctarc.2026.101476_bib0003","first-page":"102","article-title":"Epidemiological trend analysis of gastric cancer in China from 2000 to 2019","author":"Cao","year":"2021","journal-title":"Chinese J. Digest. Surg."},{"key":"10.1016\/j.ctarc.2026.101476_bib0004","first-page":"488","article-title":"China Guideline for the screening, early detection and early treatment of gastric cancer(2022, Beijing)","author":"He","year":"2022","journal-title":"China Cancer"},{"key":"10.1016\/j.ctarc.2026.101476_bib0005","first-page":"464","article-title":"Advances in the treatment of stomach cancer","author":"Zhang","year":"2021","journal-title":"Xinjiang Med. J."},{"key":"10.1016\/j.ctarc.2026.101476_bib0006","first-page":"1433","article-title":"Chemotherapy resistance-related factors in gastric cancer","author":"Li","year":"2022","journal-title":"Chem. Life"},{"key":"10.1016\/j.ctarc.2026.101476_bib0007","first-page":"1015","article-title":"Current status and prospect of treatment of advanced gastric cancer","author":"Zhao","year":"2023","journal-title":"Chinese J. Bases Clin. Gen. Surg."},{"key":"10.1016\/j.ctarc.2026.101476_bib0008","article-title":"Long non-coding RNA in gastric cancer: mechanisms and clinical implications for drug resistance","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101476_bib0009","first-page":"1","article-title":"Expression of SIRT1in 5-FU resistant gastric cancer cells and its role in Chemoresistanc","author":"Deng","year":"2020","journal-title":"J. Hebei North Univ."},{"key":"10.1016\/j.ctarc.2026.101476_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.02.005","article-title":"A non-proliferative role of pyrimidine metabolism in cancer","volume":"35","author":"Siddiqui","year":"2020","journal-title":"Mol. Metab."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101476_bib0011","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/cancers11050688","article-title":"Cancer cells tune the signaling pathways to empower de novo synthesis of nucleotides","volume":"11","author":"Villa","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101476_bib0012","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101476_bib0013","first-page":"1","article-title":"GPX3-Mediated oxidative stress affects pyrimidine metabolism levels in stomach adenocarcinoma via the AMPK\/mTOR pathway","volume":"2024","author":"Zhang","year":"2024","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101476_bib0014","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41556-023-01146-4","article-title":"De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence","volume":"25","author":"Yang","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"32","key":"10.1016\/j.ctarc.2026.101476_bib0015","doi-asserted-by":"crossref","first-page":"33035","DOI":"10.1074\/jbc.R400007200","article-title":"Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway","volume":"279","author":"Evans","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101476_bib0016","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","article-title":"Metabolic regulation of cell growth and proliferation","volume":"20","author":"Zhu","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101476_bib0017","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10120-018-0881-3","article-title":"The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells","volume":"22","author":"Mori","year":"2019","journal-title":"Gastric. Cancer"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101476_bib0018","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1016\/S0021-9258(19)68695-3","article-title":"5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity","volume":"256","author":"Kufe","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101476_bib0019","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbrc.2007.08.164","article-title":"Orotate phosphoribosyltransferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracil","volume":"363","author":"Sakamoto","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101476_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13046-024-03078-9","article-title":"The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance","volume":"43","author":"Sanese","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101476_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309014","article-title":"\u03b2-ionone enhances the inhibitory effects of 5-fluorouracil on the proliferation of gastric adenocarcinoma cells by the GSK-3\u03b2 signaling pathway","volume":"19","author":"Wang","year":"2024","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctarc.2026.101476_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114986","article-title":"Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis","volume":"164","author":"Yuan","year":"2023","journal-title":"Biomed. PharmacOther"},{"issue":"39","key":"10.1016\/j.ctarc.2026.101476_bib0023","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202157119","article-title":"Oncogenic \u03b2-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer","volume":"119","author":"Liu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101476_bib0024","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101476_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015321","article-title":"Predictive biomarkers for immunotherapy in gastric cancer: current status and emerging prospects","volume":"24","author":"Hou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101476_bib0026","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v29.i17.2515","article-title":"Novel biomarkers for early detection of gastric cancer","volume":"29","author":"Matsuoka","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"14","key":"10.1016\/j.ctarc.2026.101476_bib0027","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.3390\/ijms23147588","article-title":"Molecular and circulating biomarkers of gastric cancer","volume":"23","author":"Jelski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.ctarc.2026.101476_bib0028","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa2004413","article-title":"Trastuzumab Deruxtecan in previously treated HER2-positive gastric cancer","volume":"382","author":"Shitara","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101476_bib0029","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12885-015-1757-0","article-title":"Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker","volume":"15","author":"Boccardi","year":"2015","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101476_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32080424","article-title":"Different master regulators define proximal and distal gastric cancer: insights into prognosis and opportunities for targeted therapy","volume":"32","author":"Marano","year":"2025","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101476_bib0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101476_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104197","article-title":"Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer","volume":"198","author":"Wang","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101476_bib0033","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/annonc\/mdy540","volume":"30","author":"Boku","year":"2019","journal-title":"Ann. Oncol."},{"issue":"10294","key":"10.1016\/j.ctarc.2026.101476_bib0034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101476_bib0035","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.3390\/ijms22083805","article-title":"Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: novel translational implications","volume":"22","author":"Rihawi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101476_bib0036","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/biology13050352","article-title":"Associations between \"cancer risk\", \"inflammation\" and \"metabolic syndrome\": a scoping review","volume":"13","author":"Vitale","year":"2024","journal-title":"Biology"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101476_bib0037","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2217\/fon-2020-0989","article-title":"DNA damage response alterations in gastric cancer: knocking down a new wall","volume":"17","author":"Ricci","year":"2021","journal-title":"Fut. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101476_bib0038","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101476_bib0039","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101476_bib0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12964-024-01760-1","article-title":"The significant role of amino acid metabolic reprogramming in cancer","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ctarc.2026.101476_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115902","article-title":"The relationship between tumor metabolism and 5-fluorouracil resistance","volume":"218","author":"Hu","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101476_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117436","article-title":"Tumor-infiltrating B cells: their dual mechanistic roles in the tumor microenvironment","volume":"179","author":"Xue","year":"2024","journal-title":"Biomed. PharmacOther"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101476_bib0043","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101476_bib0044","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.ccell.2024.08.017","article-title":"From backstage to the spotlight: \u03b3\u03b4t cells in cancer","volume":"42","author":"Wiesheu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101476_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.trecan.2024.12.003","article-title":"Recent developments in myeloid immune modulation in cancer therapy","volume":"11","author":"Parvanian","year":"2025","journal-title":"Trends Cancer"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101476_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910253","article-title":"Pyrimidine biosynthetic enzyme CAD: its function, regulation, and diagnostic potential","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"34","key":"10.1016\/j.ctarc.2026.101476_bib0047","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ctarc.2026.101476_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111285","article-title":"5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomed. PharmacOther"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101476_bib0049","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/07357907.2022.2055050","article-title":"Signaling pathways involved in 5-FU drug resistance in cancer","volume":"40","author":"Danesh Pouya","year":"2022","journal-title":"Cancer Invest."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101476_bib0050","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101476_bib0051","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101476_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176979","article-title":"Resistance to 5-fluorouracil: the molecular mechanisms of development in colon cancer cells","volume":"983","author":"Radenkovi\u0107","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101476_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.949715","article-title":"Genome-wide CRISPR screening reveals pyrimidine metabolic reprogramming in 5-FU chronochemotherapy of colorectal cancer","volume":"12","author":"Niu","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:33:26Z","timestamp":1792010006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":53,"alternative-id":["S2468294226003850"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101476","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAD potentially mediates 5\u2011fluorouracil resistance in gastric cancer cells via modulation of uridine monophosphate synthetase expression","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101476"}}